The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.
J&J unveiled the first outlook for its standalone drugs and medical device businesses late last month after completing the spinoff of its consumer health company Kenvue.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: